Safe Step Act
HR 2630, the Safe Step Act, requires group health plans and health insurance issuers to establish a clear, transparent process for patients or their doctors to request exceptions to medication step therapy protocols. These protocols typically force patients to try cheaper drugs first before covering more expensive alternatives. The bill mandates that plans must approve exceptions when prior treatments failed, delay would cause serious harm, a treatment is unsafe, or a patient is stable on a previously approved drug, with strict 72-hour (or 24-hour in emergencies) decision timelines. It also requires plans to publish the exception process online and limit documentation requests to only necessary medical information. This law directly affects health insurers, employers offering health plans, and patients using step therapy for prescription drugs.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2023
Committee Review
Floor Vote
President
Introduced Apr 13, 2023
Last action Apr 13, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Apr 13, 2023
Committee
Referred to the House Committee on Education and the Workforce.
lower
Apr 13, 2023
Introduced
Introduced in House
lower
1 primary · 235 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Brad R. Wenstrup
RRepublican
Co
A. Drew Ferguson IV
RRepublican
Co
Abigail Davis Spanberger
DDemocratic
Co
Adam B. Schiff
DDemocratic
Co
Adam Smith
DDemocratic
Co
Adrian Smith
RRepublican
Co
Adriano Espaillat
DDemocratic
Co
Al Green
DDemocratic
Co
Alma S. Adams
DDemocratic
Co
Ami Bera
DDemocratic
Co
André Carson
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 2630
Scope: US
Hi! I can help you understand HR 2630. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline